retatrutide parkinson clinical trial Retatrutide approval: FDA status, clinical trial results, and when it could be available Retatrutide Achieves Up to 30.3%

Im glad Ive got years of baseline from my watch

The agency permits some unapproved drugs to be marketed if they are relied on by health care professionals to treat serious medical conditions when there is no FDA-approved drug to treat the condition or there is insufficient supply of FDA-approved drugs. Given these complexities, ideal patient candidates for Retatrutide include individuals with significant obesity, persistent insulin resistance, and metabolic syndrome who have not adequately responded to other medically supervised weight-loss strategies and who clearly understand the investigational status of the medication

Additionally, Waltzek noted the immense potential that the food and beverage industry can provide to GLP-1 users experiencing negative side effects or curious consumers worried about them

After a three-day induction phase (consisting of low-carbohydrate meals and broth), SL completed 21 consecutive days of water-only intake under close inpatient monitoring

In a large study of 125,474 people, 54% had discontinued treatment within 1 year and 72% within 2 years

National Institute of Diabetes and Digestive and Kidney Diseases, 2026a)